РУсскоязычный Архив Электронных СТатей периодических изданий
Журнал структурной химии/2015/№ 3/

CRYSTAL STRUCTURE AND ANTITUMOR ACTIVITIES OF THE DICHLORIDE 2,6-BIS(1-PHENYLBENZIMIDAZOL-2-YL)PYRIDINE COPPER(II) COMPLEX

A new complex Cu(bpbp)Cl2⋅DMF⋅H2O is synthesized by treatment of CuCl2 with 2,6-bis(1phenylbenzimidazol-2-yl)pyidine in DMF. Its structure is characterized by elemental, IR, UV, and single crystal X-ray structure analyses. For the complex: crystal system, triclinic, space group Pī, a = 1.0537(1) nm, b = 1.1735(1) nm, c = 1.3749(2) nm, α = 112.275(2)°, β = 91.531(2)°, γ = 97.700(2)°, V = 1.553(4) nm3, Z = 2. In a distorted trigonal bipyramidal geometry the Cu(II) ion is coordinated by three nitrogen atoms from 2,6-bis(1-phenylbenzimidazol-2-yl)pyridine and two chloride ions. The antiproliferative activities of the complex are screened by MTT assay against HepG2, Huh7, Eca109, and Eca9706 cancer cells. The complex exhibits specific inhibition on Eca9706 cancer cells with the IC50 value of 28 μM after 48 h treatment. CCDC: 968927.

Авторы
Тэги
Тематические рубрики
Предметные рубрики
В этом же номере:
Резюме по документу**
Том 56, 3 ЖУРНАЛ СТРУКТУРНОЙ ХИМИИ Май – июнь КРАТКИЕ СООБЩЕНИЯ UDC 548.73:541.49:546.562 CRYSTAL STRUCTURE AND ANTITUMOR ACTIVITIES OF THE DICHLORIDE 2,6-BIS(1-PHENYLBENZIMIDAZOL-2-YL)PYRIDINE COPPER(II) COMPLEX Q.-W. Huang1, S.-G. Liu1, G.-B. Li, S.-X. Wang2, W.-Y. Su1 , D.-M. Liang1, S.-Q. Mao1 1School of Chemistry & Chemical Engineering, Lingnan Normal University, Zhanjiang, P.R. China 2 E-mail: lsgui@sohu.com Institute of Molecular Medicine, Medical School of Shenzhen University, Shenzhen, P.R. China Received November, 24, 2013 Revised January, 06, 2015 A new complex Cu(bpbp)Cl2 DMFH2O is synthesized by treatment of CuCl2 with 2,6-bis(1phenylbenzimidazol-2-yl)pyidine in DMF. <...> Its structure is characterized by elemental, IR, UV, and single crystal X-ray structure analyses. <...> In a distorted trigonal bipyramidal geometry the Cu(II) ion is coordinated by three nitrogen atoms from 2,6-bis(1-phenylbenzimidazol-2-yl)pyridine and two chloride ions. <...> The antiproliferative activities of the complex are screened by MTT assay against HepG2, Huh7, Eca109, and Eca9706 cancer cells. <...> The complex exhibits specific inhibition on Eca9706 cancer cells with the IC50 value of 28 µM after 48 h treatment. <...> The widespread success of cisplatin in the clinical treatment of various types of neoplasias has placed coordination chemistry of metal-based drugs in the frontline in the fight against cancer [ 1—4]. <...> However, the accumulation of metal ions in the body can lead to deleterious effects and unavoidable toxicity. <...> Benzimidazole derivatives are important pharmacophores in drugs that display a diversity of pharmacological activities, such as anti-inflammatory, antioxidant, gastroprotective, and antiparasitic activities [ 6 ]. <...> Many DNA minor groove binders containing one or more benzimidazole heterocycles endowed with promising antitumor and antiparasitic activities have been reported to date [ 7, 8 ]. <...> Studies have showed that the intercalating abilities of the complexes depended on the types of metal ions, the ligand donor atoms, the planarity of ligands, and the coordination geometry [ 9 ]. <...> In this article, we synthesized a new copper(II) complex based on 2,6-bis(1-phenylbenzimidazol-2-yl)pyridine and investigated its antitumor activities. <...> The result demonstrates that the dichloride 2,6-bis <...>
** - вычисляется автоматически, возможны погрешности

Похожие документы: